In all 45 cases the device was easily implanted without any intraoperative complications. One patient with persistent incontinence after VICTO-Implantation required a smaller OC. The pad per day usage improved from 6.4 to 1.6 and the continence rate (max. 1p/d) was 53,3%. The overall satisfaction was 83,8% and 88,6% would undergo the same operation again. Only 4 patients had an improvement less than 50%, all of them are not fully activated yet and may improve more with future adjustments.
They concluded that the device provides adjustability in regulating pressure in situ. In this study there was 45 patients, 91,1% had at least an improvement of 50% and these short results are promising and challenge prior AUS series. Adjusting the system pressure to the lowest level providing continence may reduce the long-term rate of erosions and &[Prime]sub cuff atrophy&[Prime], however such data are not yet available
Presented by: Peter Weibl, MD, PhD,Associate Professor, Korneuburg, Austria, Deputy of head physician (chief senior consultant) of Urologic Department
Co-Authors: Ghazal Ameli, Michael Rutkowski, Wilhelm Alexander Huebner, Korneuburg, Austria
Written by: Bilal Farhan, MD, Clinical Instructor, Female Urology and Voiding Dysfunction, Department of Urology, University of California, Irvine @BilalfarhanMD at the American Urological Association's 2019 Annual Meeting (AUA 2019), May 3 – 6, 2019 in Chicago, Illinois